CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Shareholders Equity (Quarterly): 292.26M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 292.26M |
| September 30, 2023 | 326.19M |
| June 30, 2023 | 108.41M |
| March 31, 2023 | 104.19M |
| December 31, 2022 | 36.15M |
| September 30, 2022 | 60.18M |
| June 30, 2022 | 82.46M |
| March 31, 2022 | 107.38M |
| December 31, 2021 | 132.94M |
| September 30, 2021 | 87.06M |
| June 30, 2021 | 107.09M |
| March 31, 2021 | 127.65M |
| December 31, 2020 | 142.71M |
| September 30, 2020 | 156.64M |
| June 30, 2020 | 165.61M |
| March 31, 2020 | 175.05M |
| December 31, 2019 | 186.35M |
| September 30, 2019 | 212.59M |
| June 30, 2019 | 236.06M |
| March 31, 2019 | 257.63M |
| December 31, 2018 | 170.42M |
| Date | Value |
|---|---|
| September 30, 2018 | 188.13M |
| June 30, 2018 | 199.21M |
| March 31, 2018 | 212.20M |
| December 31, 2017 | 84.95M |
| September 30, 2017 | 86.50M |
| June 30, 2017 | 2.139M |
| March 31, 2017 | 9.227M |
| December 31, 2016 | 3.937M |
| September 30, 2016 | 10.21M |
| June 30, 2016 | 15.42M |
| March 31, 2016 | 21.85M |
| December 31, 2015 | 28.12M |
| September 30, 2015 | 33.49M |
| June 30, 2015 | 17.68M |
| March 31, 2015 | 18.27M |
| December 31, 2014 | 13.85M |
| September 30, 2014 | 26.13M |
| June 30, 2014 | 8.477M |
| March 31, 2014 | 11.38M |
| December 31, 2013 | 18.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
36.15M
Minimum
Dec 2022
326.19M
Maximum
Sep 2023
149.84M
Average
132.94M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences Inc | 17.46B |
| Assure Holdings Corp | -15.34M |
| Societal CDMO Inc (DELISTED) | 58.66M |
| AN2 Therapeutics Inc | 124.70M |
| Madrigal Pharmaceuticals Inc | 405.33M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 434.69M |
| Total Liabilities (Quarterly) | 142.43M |
| Debt to Equity Ratio | 0.3735 |
| Current Ratio | 10.96 |
| Net Debt Paydown Yield | -0.17% |